My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Profound Medical Corp. - common stock
(NQ:
PROF
)
5.560
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
5.560
Bid (Size)
5.000 (10)
Ask (Size)
5.940 (1)
Prev. Close
5.560
Today's Range
5.560 - 5.560
52wk Range
3.760 - 9.170
Shares Outstanding
20,208,948
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Profound Medical Congratulates the Busch Center for Achieving 500th TULSA Procedure Milestone
October 16, 2025
Clinical validation from the Busch Center highlights the proven, scalable innovation driving a paradigm shift in prostate care — delivering precision treatment and better patient outcomes
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in the Stifel 2025 Healthcare Conference
October 14, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Performance
YTD
-29.6%
-29.6%
1 Month
+37.6%
+37.6%
3 Month
-2.4%
-2.4%
6 Month
+16.3%
+16.3%
1 Year
-26.9%
-26.9%
More News
Read More
Earnings Scheduled For August 14, 2025
August 14, 2025
Via
Benzinga
Earnings Scheduled For May 8, 2025
May 08, 2025
Via
Benzinga
Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter
October 07, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference
August 28, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Posts Wider Loss in Q2
August 14, 2025
Via
The Motley Fool
Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
September 23, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Second Quarter 2025 Financial Results
August 14, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
July 24, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
June 10, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®
June 04, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
May 14, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
May 13, 2025
Via
Benzinga
Expedia, Wolfspeed, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session
May 09, 2025
Via
Benzinga
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
May 09, 2025
Via
Benzinga
Profound Medical Announces First Quarter 2025 Financial Results
May 08, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
April 30, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
April 29, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
April 29, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
April 25, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
April 21, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
April 17, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow
April 17, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical AUA 2025 Investor Event Agenda
April 15, 2025
From
Profound Medical Corp.
Via
GlobeNewswire
Frequently Asked Questions
Is Profound Medical Corp. - common stock publicly traded?
Yes, Profound Medical Corp. - common stock is publicly traded.
What exchange does Profound Medical Corp. - common stock trade on?
Profound Medical Corp. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Profound Medical Corp. - common stock?
The ticker symbol for Profound Medical Corp. - common stock is PROF on the Nasdaq Stock Market
What is the current price of Profound Medical Corp. - common stock?
The current price of Profound Medical Corp. - common stock is 5.560
When was Profound Medical Corp. - common stock last traded?
The last trade of Profound Medical Corp. - common stock was at 10/16/25 04:00 PM ET
What is the market capitalization of Profound Medical Corp. - common stock?
The market capitalization of Profound Medical Corp. - common stock is 112.36M
How many shares of Profound Medical Corp. - common stock are outstanding?
Profound Medical Corp. - common stock has 112M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.